Versatile High Affinity Antibody to DOTA Chelates of Multiple Radionuclides

Exclusively Licensed

Compositions and methods for the treatment of cancer and infectious disease The compositions include engineered proteins that specifically bind a target (e g, a cellular protein) on a cancerous cell or a pathogen and a metal chelate comprising DOT A, or an active variant thereof, and a metal ion such as a radionuclide are disclosed By virtue of the multiple binding sites, the engineered protein effectively delivers a metal chelate to a cell one wishes to destroy.

Researchers

Karl Dane Wittrup / Kelly Davis

Departments: Department of Chemical Engineering
Technology Areas: Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living

  • versatile high affinity antibody to dota chelates of multiple radionuclides
    Spain | Granted | 2,403,530
  • engineered proteins with high affinity for dota chelates
    United States of America | Granted | 8,648,176
  • versatile high affinity antibody to dota chelates of multiple radionuclides
    European Patent Convention | Granted | 2,403,530
  • versatile high affinity antibody to dota chelates of multiple radionuclides
    Switzerland | Granted | 2,403,530
  • versatile high affinity antibody to dota chelates of multiple radionuclides
    Italy | Granted | 2,403,530
  • versatile high affinity antibody to dota chelates of multiple radionuclides
    Ireland | Granted | 2,403,530
  • versatile high affinity antibody to dota chelates of multiple radionuclides
    United Kingdom | Granted | 2,403,530
  • versatile high affinity antibody to dota chelates of multiple radionuclides
    Belgium | Granted | 2,403,530
  • versatile high affinity antibody to dota chelates of multiple radionuclides
    Germany | Granted | 2,403,530
  • versatile high affinity antibody to dota chelates of multiple radionuclides
    France | Granted | 2,403,530

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies